HF
PCSA icon

HRT Financial’s Processa Pharmaceuticals PCSA Stock Holding History

HRT Financial’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,691
Closed -$56K – 4496
2025
Q4 		$56K Buy
+19,691
New +$138K ﹤0.01% 2864
2025
Q1 		– Sell
-1,279
Closed -$28K – 3178
2024
Q4 		$28K Buy
+1,279
New +$36.1K ﹤0.01% 2172
2024
Q1 		– Sell
-23
Closed -$3K – 2894
2023
Q4 		$3K Sell
23
-16
-41% -$3.57K ﹤0.01% 2154
2023
Q3 		$4K Buy
+39
New +$7.37K ﹤0.01% 2201

Other funds holding PCSA

CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's PCSA Position: Q1 2026 in Review

HRT Financial sold out of Processa Pharmaceuticals (PCSA) in Q1 2026, closing a stake of 19,691 shares — an estimated $56K sold.

HRT Financial first reported a position in PCSA in Q3 2023 and held it in 4 quarters. The position peaked at $56K in Q4 2025. 10 funds tracked by Wall St. Rank hold PCSA as of Q1 2026.

  • HRT Financial reported no remaining Processa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 19,691 Processa Pharmaceuticals shares in Q1 2026, an estimated $56K.
  • HRT Financial first reported a position in Processa Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • HRT Financial's Processa Pharmaceuticals position peaked at $56K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.